Concepta Share Price (CPT)

4.90 0.00 (0.00%) delayed: 6:23PM BST
Bid price 4.80 Open price 4.90
Ask price 5.00 Prev close 4.90
High price 4.90 Spread 4.00%
Low price 4.88 Volume 42,000

Register now for FREE live Concepta share prices, Concepta stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Concepta Level 2 Data, indepth research tools and investor commentary for Concepta (CPT) and other London Stock Exchange equities.

Concepta Share Price Chart

Advanced Charts >>

Register now for FREE Concepta share price charts

Concepta Share Price Information

Name Concepta Epic CPT
Sector Health Care Equipment & Services ISIN GB00BYZ2R301
Activites Concepta plc (formerly Frontier Resources International plc) is a pioneering UK healthcare company that has developed a proprietary platform and products targeted at the personalised mobile health market with a primary focus on women's fertility and specifically unexplained infertility*. Founded in 2013, Concepta has developed a revolutionary flagship product 'MyLotus' for home self-testing that helps women with unexplained infertility to conceive. MyLotus is the only consumer product which allows both quantitative and qualitative measurements of measurement of a woman's personal hCG and LH hormone levels in an easy to use home test to facilitate higher conception rates and early diagnosis of any fertility problems. Competitor products currently only allow qualitative measurement and are based on the 'average woman'. Concepta has a defined route to market for its new 'My Lotus' product with Regulatory approvals for launch in China in place for 2016 and CE-Marking for UK and Europe to follow in 2018 where the revenue potential of the Chinese and EU infertility market is worth c.£600m per annum for the company. Index n/a

Concepta Key Numbers

Latest Share Price (p) 4.90 Net Gearing (%) -28.64
Market Capitalisation (£m) 6.77 Gross Gearing (%) 15.54
Shares in issue (m) 138.20 Debt Ratio 2.07
P/E Ratio -2.45 Debt-to-Equity Ratio 0.12
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.18
Dividend Yield (%) 0.00 Price to book value 2.30
Dividend cover (x) 0.00 ROCE (%) -81.67
Earning per share (p) -2.00 EPS Growth (%) 33.33
52 week high / low 12.25 / 4.40 DPS Growth (%) n/a

Concepta Director Deals

Dec.Date Type Director Pos No. of Shares
30/11/2017 BUY Erik Henau CEO 100,000
26/06/2017 BUY Erik Henau CEO 80,000
29/09/2008 BUY Patrick Cottrell RES 70,000

More Concepta Director Deals >>

Concepta Company News

10:10 17/07/2018

Concepta appoints Matthew Walls as Chairman

UK healthcare group Concepta said Tuesday, it had appointed Matthew Walls as Chairman. Adam Reynolds, currently Chairman, is expected to move to the role of Non-Executive Director. Walls has had extensive senior and board-level experience in public companies, particularly in pharmaceutical,...

07:00 17/07/2018

Board Changes

RNS Number : 8073U Concepta PLC 17 July 2018   17 July 2018 Concepta PLC (" Concepta " or the " Company ")  Board Changes Concepta PLC (AIM:CPT),  the UK healthcare company and developer of a proprietary product targeted at the mobile health market and with a...

10:31 19/06/2018

Castleton swings to pretax profit buoyed by revenue, cash generation growth

Software group Castleton Technology said Tuesday it swung to a pre-tax profit in the 12 months to the end of March supported by an increase in revenue and strong cash generation. For the year to 31 March 2018, group pre-tax profit rose to £1.8m from a loss of £0.5m the previous year, revenue...

More Concepta Company News >>

Register now for FREE Concepta company news

Concepta Share Price Discussions

8 months ago

MyLotus beginning to blossom (CPT)

Frontier Resources (AIM:FRI), agreed to acquire Concepta Diagnostics Limited (“Conceptaâ€), a pioneering UK healthcare company established in 2013, that has developed proprietary products and a platform, which targets the personalised mobile health market with a primary focus on women’s...

10 months ago

MyLotus beginning to blossom (CPT)

Frontier Resources (AIM:FRI), agreed to acquire Concepta Diagnostics Limited (“Conceptaâ€), a pioneering UK healthcare company established in 2013, that has developed proprietary products and a platform, which targets the personalised mobile health market with a primary focus on women’s...

Register now for FREE Concepta share price discussions